The Global Iodine Deficiency Drug Market is valued approximately at USD 4.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.76% over the forecast period 2024-2032 ...
Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce the successful completion of a key phase in human testing of its Health Canada-licensed ...